Noubar Afeyan, billionaire biotech mogul and co-founder of Moderna, has issued an urgent call for government regulation of autonomous AI agents being deployed commercially by technology companies, warning that delayed oversight risks repeating catastrophic failures from pharmaceutical history. Speaking at the Bloomberg New Economy Forum in New Delhi on October 13, Afeyan invoked the thalidomide tragedy of the 1950s and 1960s—in which a drug taken by pregnant women caused severe birth defects—as a cautionary precedent for why companies must establish safety protocols before release.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.